Open original FDA record ↗Recall record
- FDA identifier
- Z-1650-2026
- Company in FDA record
- Medline Industries, LP
- FDA classification date
- Mar 27, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Elevated endotoxin levels identified in affected lots. Issue may elicit strong inflammatory response if used, including local tissue irritation, delayed wound healing, or systemic effects such as fever and hypotension. In severe cases, septic shock may result.
Source facts
- Action
- Firm began notifying customers on 2/10/26 via "Urgent Medical Device Recall" letters. Customers were instructed to immediately locate and quarantine all affected product. Affected product must be destroyed. Customer should respond to the firm to confirm quantity of affected product in inventory. The customer will receive credit from the firm once the response is submitted. Distributors should notify any of their affected downstream accounts. If you have any questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.
- Initiated
- 2026-02-10
- Root cause
- Under Investigation by firm
- Distribution
- Domestic distribution nationwide US. International distribution to Mexico and Panama.
- Recall number
- Z-1650-2026
- Recall status
- Open, Classified
- CDRH record ID
- 218891
- FDA classified
- 2026-03-27
- Recall event number
- 98484